The majority of children presenting to primary care with abdominal pain develop chronic abdominal pain, with a median duration of 7.5 months.
As irritable bowel syndrome (IBS) remains a complicated condition to treat with an etiology that’s still unknown, it’s difficult for physicians to find the best proven therapies among new remedies and the variety of pharmacological and nondrug options they have been trying for years.
Patients taking linaclotide experience clinically meaningful improvement in abdominal and bowel symptoms, which closely correlate with the US Food and Drug Administration’s new criteria for irritable bowel syndrome with constipation (IBS-C).
While it’s important for nutrition and an integral part of patients’ lives, food also plays a role in functional gastrointestinal disorders such as irritable bowel syndrome (IBS).
Researchers using fMRI to study neural activity in IBS patients report that the processing and perception of visceral stimuli can be modulated by psychological and cognitive treatment.